Rockefeller Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.3K Sell
433
-194
-31% -$4.21K ﹤0.01% 4072
2025
Q4
$13.8K Buy
627
+225
+56% +$4.06K ﹤0.01% 3671
2025
Q3
$4.88K Buy
+402
New +$5.44K ﹤0.01% 3877
2023
Q1
Sell
-1,172
Closed -$52K 3722
2022
Q4
$52K Sell
1,172
-101
-8% -$4.57K ﹤0.01% 2366
2022
Q3
$60K Buy
1,273
+1,142
+872% +$62.6K ﹤0.01% 2252
2022
Q2
$7K Buy
131
+29
+28% +$2.38K ﹤0.01% 3325
2022
Q1
$11K Sell
102
-2
-2% -$233 ﹤0.01% 3010
2021
Q4
$15K Buy
104
+2
+2% +$270 ﹤0.01% 2793
2021
Q3
$12K Buy
102
+2
+2% +$220 ﹤0.01% 2813
2021
Q2
$9K Sell
100
-4
-4% -$357 ﹤0.01% 2826
2021
Q1
$9K Sell
104
-14
-12% -$1.3K ﹤0.01% 2655
2020
Q4
$11K Sell
118
-19,101
-99% -$1.97M ﹤0.01% 2213
2020
Q3
$2.18M Sell
19,219
-11,186
-37% -$1.18M 0.02% 401
2020
Q2
$3.01M Sell
30,405
-467
-2% -$37.3K 0.03% 317
2020
Q1
$1.99M Buy
30,872
+27,088
+716% +$1.9M 0.03% 338
2019
Q4
$226K Buy
3,784
+1,904
+101% +$117K ﹤0.01% 741
2019
Q3
$111K Sell
1,880
-46
-2% -$2.94K ﹤0.01% 773
2019
Q2
$124K Hold
1,926
﹤0.01% 649
2019
Q1
$122K Buy
+1,926
New +$101K ﹤0.01% 710

Other funds holding TNDM

Rockefeller Capital Management's TNDM Position: Q1 2026 in Review

Rockefeller Capital Management reduced its Tandem Diabetes Care (TNDM) stake by 31% in Q1 2026, selling an estimated $4.21K and leaving 433 shares worth $8.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4072.

Rockefeller Capital Management first reported a position in TNDM in Q1 2019 and has held it in 19 quarters since. The position peaked at $3.01M in Q2 2020. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Rockefeller Capital Management held 433 shares of Tandem Diabetes Care worth $8.3K as of Q1 2026.
  • Rockefeller Capital Management sold 194 Tandem Diabetes Care shares in Q1 2026, an estimated $4.21K.
  • Tandem Diabetes Care made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4072 holding.
  • Rockefeller Capital Management first reported a position in Tandem Diabetes Care in Q1 2019 and has held it in 19 quarters since.
  • Rockefeller Capital Management's Tandem Diabetes Care position peaked at $3.01M in Q2 2020.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.